The global bioinformatics market was valued at $2.9 billion in 2012 and is poised to reach $7.5 billion by 2017 at a CAGR of 20.9%. The growth of the bioinformatics market is driven by decrease in cost of DNA sequencing, increasing government initiatives and funding, and growing use of bioinformatics in drug discovery and biomarkers development processes. It is expected that the market will offer opportunities for bioinformatics solutions manufacturers with the introduction and adoption of upcoming technologies such as nanopore sequencing and cloud computing. However, factors such as dearth of skilled personnel to ensure proper use of bioinformatics tools and lack of integration of a wide variety of data generated through various bioinformatics platforms are hindering the growth of the market. Manufacturers of bioinformatics solutions will face further challenges with regard to industry consolidation and management of high volume data.
Download Free PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=39
Bioinformatics is a scientific discipline that deals with the retrieval, storage, processing, analysis, and management of biological information through computational techniques. It uses mathematics, biology, and information technology to understand the biological importance of an extensive variety of data. Bioinformatics technologies are used in various pharmaceutical and biotechnology sectors. It is majorly used in the medical sector, driven by the increasing use of bioinformatics for the drug discovery and development process.
Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=39
North America accounted for the largest market share of the bioinformatics market, followed by Europe, in 2012. However, Asian and Latin American countries represent emerging markets, owing to a rise in research outsourcing by pharmaceutical giants, increasing number of Contract Research Organizations (CROs), rise in public and private sector investment, and growing industry -academia partnerships. The major players in the bioinformatics market are Accelrys, Inc. (U.S.), Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC bio. (Denmark).
Browse related reports:
Genomics Market by Products - [Instruments (NGS
platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA
Extraction & Purification, Sequencing)], Services (Sequencing &
Microarray Services, and Software) - Global Forecast to 2018
Proteomics Market by Technology (Protein
Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography,
Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) -
Instruments, Reagents & Services - Global Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/healthcareit
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets